The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches
dc.contributor.author | Soki, Fabiana N. | en_US |
dc.contributor.author | Li, Xin | en_US |
dc.contributor.author | Berry, Janice | en_US |
dc.contributor.author | Koh, Amy | en_US |
dc.contributor.author | Sinder, Benjamin P. | en_US |
dc.contributor.author | Qian, Xu | en_US |
dc.contributor.author | Kozloff, Kenneth M. | en_US |
dc.contributor.author | Taichman, Russell S. | en_US |
dc.contributor.author | McCauley, Laurie K. | en_US |
dc.date.accessioned | 2012-12-11T17:37:25Z | |
dc.date.available | 2014-03-03T15:09:25Z | en_US |
dc.date.issued | 2013-01 | en_US |
dc.identifier.citation | Soki, Fabiana N.; Li, Xin; Berry, Janice; Koh, Amy; Sinder, Benjamin P.; Qian, Xu; Kozloff, Kenneth M.; Taichman, Russell S.; McCauley, Laurie K. (2013). "The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches ." Journal of Cellular Biochemistry 114(1): 67-78. <http://hdl.handle.net/2027.42/94483> | en_US |
dc.identifier.issn | 0730-2312 | en_US |
dc.identifier.issn | 1097-4644 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/94483 | |
dc.description.abstract | Hematopoietic stem cells (HSC) are maintained in a tightly regulated bone microenvironment constituted by a rich milieu of cells. Bone cells such as osteoblasts are associated with niche maintenance as regulators of the endosteal microenvironment. Bone remodeling also plays a role in HSC mobilization although it is poorly defined. The effects of zoledronic acid (ZA), a potent bisphosphonate that inhibits bone resorption, were investigated on bone marrow cell populations focusing on HSCs, and the endosteal and vascular niches in bone. ZA treatment significantly increased bone volume and HSCs in both young and adult mice (4 week and 4 month old, respectively). ZA increased vessel numbers with no overall change in vascular volume in bones of young and had no effect on vasculature in adult mice. Since both young and adult mice had increased HSCs and bone mass with differing vasculature responses, this suggests that ZA indirectly supports HSCs via the osteoblastic niche and not the vascular niche. Additionally, gene expression in Lin‐ cells demonstrated increased expression of self‐renewal‐related genes Bmi1 and Ink4a suggesting a role of ZA in the modulation of cell commitment and differentiation toward a long‐term self‐renewing cell. Genes that support the osteoblastic niche, BMP2 and BMP6 were also augmented in ZA treated mice. In conclusion, ZA‐induced HSC expansion occurs independent of the vascular niche via indirect modulation of the osteoblastic niche. J. Cell. Biochem. 114: 67–78, 2012. © 2012 Wiley Periodicals, Inc. | en_US |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | HEMATOPOIETIC STEM CELLS | en_US |
dc.subject.other | ZOLEDRONIC ACID | en_US |
dc.subject.other | BISPHOSPHONATE | en_US |
dc.subject.other | BLOOD VESSELS | en_US |
dc.subject.other | BONE VASCULATURE | en_US |
dc.subject.other | NICHE | en_US |
dc.title | The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Molecular, Cellular and Developmental Biology | en_US |
dc.subject.hlbsecondlevel | Genetics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Periodontics and Oral Medicine, The University of Michigan School of Dentistry, 1011 N. University Avenue, Ann Arbor, MI 48109. | en_US |
dc.contributor.affiliationum | Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Biologic and Materials Sciences, University of Michigan School of Dentistry, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Orthopaedic Surgery, University of Michigan Medical School, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationother | Basic Science and Craniofacial Biology, College of Dentistry, New York University, New York, New York | en_US |
dc.identifier.pmid | 22833499 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/94483/1/24301_ftp.pdf | |
dc.identifier.doi | 10.1002/jcb.24301 | en_US |
dc.identifier.source | Journal of Cellular Biochemistry | en_US |
dc.identifier.citedreference | Santini D, Vincenzi B, Dicuonzo G, Avvisati G, Massacesi C, Battistoni F, Gavasci M, Rocci L, Tirindelli MC, Altomare V, Tocchini M, Bonsignori M, Tonini G. 2003. Zoledronic acid induces significant and long‐lasting modifications of circulating angiogenic factors in cancer patients. Clin Cancer Res 9: 2893 – 2897. | en_US |
dc.identifier.citedreference | Arai F, Hirao A, Ohmura M, Sato H, Matsuoka S, Takubo K, Ito K, Koh GY, Suda T. 2004. Tie2/angiopoietin‐1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118: 149 – 161. | en_US |
dc.identifier.citedreference | Bianco P. 2011. Bone and the hematopoietic niche: A tale of two stem cells. Blood 117: 5281 – 5288. | en_US |
dc.identifier.citedreference | Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC, Martin RP, Schipani E, Divieti P, Bringhurst FR, Milner LA, Kronenberg HM, Scadden DT. 2003. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425: 841 – 846. | en_US |
dc.identifier.citedreference | Challen GA, Boles NC, Chambers SM, Goodell MA. 2010. Distinct hematopoietic stem cell subtypes are differentially regulated by TGF‐beta1. Cell Stem Cell 6: 265 – 278. | en_US |
dc.identifier.citedreference | Cho KA, Joo SY, Han HS, Ryu KH, Woo SY. 2010. Osteoclast activation by receptor activator of NF‐kappaB ligand enhances the mobilization of hematopoietic progenitor cells from the bone marrow in acute injury. Int J Mol Med 26: 557 – 563. | en_US |
dc.identifier.citedreference | Ellis SL, Grassinger J, Jones A, Borg J, Camenisch T, Haylock D, Bertoncello I, Nilsson SK. 2011. The relationship between bone, hemopoietic stem cells, and vasculature. Blood 118: 1516 – 1524. | en_US |
dc.identifier.citedreference | Grassinger J, Haylock DN, Williams B, Olsen GH, Nilsson SK. 2010. Phenotypically identical hemopoietic stem cells isolated from different regions of bone marrow have different biologic potential. Blood 116: 3185 – 3196. | en_US |
dc.identifier.citedreference | Guldberg RE, Duvall CL, Peister A, Oest ME, Lin AS, Palmer AW, Levenston ME. 2008. 3D imaging of tissue integration with porous biomaterials. Biomaterials 29: 3757 – 3761. | en_US |
dc.identifier.citedreference | Jung Y, Song J, Shiozawa Y, Wang J, Wang Z, Williams B, Havens A, Schneider A, Ge C, Franceschi RT, McCauley LK, Krebsbach PH, Taichman RS. 2008. Hematopoietic stem cells regulate mesenchymal stromal cell induction into osteoblasts thereby participating in the formation of the stem cell niche. Stem Cells 26: 2042 – 2051. | en_US |
dc.identifier.citedreference | Kiel MJ, Yilmaz OH, Iwashita T, Yilmaz OH, Terhorst C, Morrison SJ. 2005. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121: 1109 – 1121. | en_US |
dc.identifier.citedreference | Kollet O, Dar A, Shivtiel S, Kalinkovich A, Lapid K, Sztainberg Y, Tesio M, Samstein RM, Goichberg P, Spiegel A, Elson A, Lapidot T. 2006. Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat Med 12: 657 – 664. | en_US |
dc.identifier.citedreference | Lee MY, Fukunaga R, Lee TJ, Lottsfeldt JL, Nagata S. 1991. Bone modulation in sustained hematopoietic stimulation in mice. Blood 77: 2135 – 2141. | en_US |
dc.identifier.citedreference | Li X, Liao J, Park SI, Koh AJ, Sadler WD, Pienta KJ, Rosol TJ, McCauley LK. 2011. Drugs which inhibit osteoclast function suppress tumor growth through calcium reduction in bone. Bone 48: 1354 – 1361. | en_US |
dc.identifier.citedreference | Lymperi S, Ersek A, Ferraro F, Dazzi F, Horwood NJ. 2011. Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo. Blood 117: 1540 – 1549. | en_US |
dc.identifier.citedreference | Metcalf S, Pandha HS, Morgan R. 2011. Antiangiogenic effects of zoledronate on cancer neovasculature. Future Oncol 7: 1325 – 1333. | en_US |
dc.identifier.citedreference | Miyamoto K, Yoshida S, Kawasumi M, Hashimoto K, Kimura T, Sato Y, Kobayashi T, Miyauchi Y, Hoshi H, Iwasaki R, Miyamoto H, Hao W, Morioka H, Chiba K, Kobayashi T, Yasuda H, Penninger JM, Toyama Y, Suda T, Miyamoto T. 2011. Osteoclasts are dispensable for hematopoietic stem cell maintenance and mobilization. J Exp Med 208: 2175 – 2181. | en_US |
dc.identifier.citedreference | Parfitt AM. 2000. The mechanism of coupling: A role for the vasculature. Bone 26: 319 – 323. | en_US |
dc.identifier.citedreference | Park IK, Qian D, Kiel M, Becker MW, Pihalja M, Weissman IL, Morrison SJ, Clarke MF. 2003. Bmi‐1 is required for maintenance of adult self‐renewing haematopoietic stem cells. Nature 423: 302 – 305. | en_US |
dc.identifier.citedreference | Park SI, Liao J, Berry JE, Li X, Koh AJ, Michalski ME, Eber MR, Soki FN, Sadler D, Sud S, Tisdelle S, Daignault SD, Nemeth JA, Snyder LA, Wronski TJ, Pienta KJ, McCauley LK. 2012. Cyclophosphamide creates a receptive microenvironment for prostate cancer skeletal metastasis. Cancer Res 72: 2522 – 2532. | en_US |
dc.identifier.citedreference | Prisby R, Guignandon A, Vanden Bossche A, Mac‐Way F, Linossier MT, Thomas M, Laroche N, Malaval L, Langer M, Peter ZA, Peyrin F, Vico L, Lafage‐Proust MH. 2011. Intermittent PTH(1‐84) is osteoanabolic but not osteoangiogenic and relocates bone marrow blood vessels closer to bone‐forming sites. J Bone Miner Res 26: 2583 – 2596. | en_US |
dc.identifier.citedreference | Rizo A, Dontje B, Vellenga E, de HG, Schuringa JJ. 2008. Long‐term maintenance of human hematopoietic stem/progenitor cells by expression of BMI1. Blood 111: 2621 – 2630. | en_US |
dc.identifier.citedreference | Rodan GA, Fleisch HA. 1996. Bisphosphonates: Mechanisms of action. J Clin Invest 97: 2692 – 2696. | en_US |
dc.identifier.citedreference | Rogers TL, Holen I. 2011. Tumour macrophages as potential targets of bisphosphonates. J Transl Med 9: 177. | en_US |
dc.identifier.citedreference | Shiozawa Y, Jung Y, Ziegler AM, Pedersen EA, Wang J, Wang Z, Song J, Wang J, Lee CH, Sud S, Pienta KJ, Krebsbach PH, Taichman RS. 2010. Erythropoietin couples hematopoiesis with bone formation. PLoS ONE 5: e10853. | en_US |
dc.identifier.citedreference | Smith KS, Chanda SK, Lingbeek M, Ross DT, Botstein D, van LM, Cleary ML. 2003. Bmi‐1 regulation of INK4A‐ARF is a downstream requirement for transformation of hematopoietic progenitors by E2a‐Pbx1. Mol Cell 12: 393 – 400. | en_US |
dc.identifier.citedreference | Takahashi T, Wada T, Mori M, Kokai Y, Ishii S. 1996. Overexpression of the granulocyte colony‐stimulating factor gene leads to osteoporosis in mice. Lab Invest 74: 827 – 834. | en_US |
dc.identifier.citedreference | Visnjic D, Kalajzic Z, Rowe DW, Katavic V, Lorenzo J, Aguila HL. 2004. Hematopoiesis is severely altered in mice with an induced osteoblast deficiency. Blood 103: 3258 – 3264. | en_US |
dc.identifier.citedreference | Wan C, Gilbert SR, Wang Y, Cao X, Shen X, Ramaswamy G, Jacobsen KA, Alaql ZS, Eberhardt AW, Gerstenfeld LC, Einhorn TA, Deng L, Clemens TL. 2008. Activation of the hypoxia‐inducible factor‐1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci USA 105: 686 – 691. | en_US |
dc.identifier.citedreference | Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert SR, Bouxsein ML, Faugere MC, Guldberg RE, Gerstenfeld LC, Haase VH, Johnson RS, Schipani E, Clemens TL. 2007. The hypoxia‐inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 117: 1616 – 1626. | en_US |
dc.identifier.citedreference | Winter MC, Coleman RE. 2009. Bisphosphonates in breast cancer: Teaching an old dog new tricks. Curr Opin Oncol 21: 499 – 506. | en_US |
dc.identifier.citedreference | Wood J, Bonjean K, Ruetz S, Bellahcene A, Devy L, Foidart JM, Castronovo V, Green JR. 2002. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302: 1055 – 1061. | en_US |
dc.identifier.citedreference | Wu X, Pang L, Lei W, Lu W, Li J, Li Z, Frassica FJ, Chen X, Wan M, Cao X. 2010. Inhibition of Sca‐1‐positive skeletal stem cell recruitment by alendronate blunts the anabolic effects of parathyroid hormone on bone remodeling. Cell Stem Cell 7: 571 – 580. | en_US |
dc.identifier.citedreference | Yang L, Bryder D, Adolfsson J, Nygren J, Mansson R, Sigvardsson M, Jacobsen SE. 2005. Identification of Lin(−)Sca1(+)kit(+)CD34(+)Flt3‐ short‐term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. Blood 105: 2717 – 2723. | en_US |
dc.identifier.citedreference | Yao Z, Lafage‐Proust MH, Plouet J, Bloomfield S, Alexandre C, Vico L. 2004. Increase of both angiogenesis and bone mass in response to exercise depends on VEGF. J Bone Miner Res 19: 1471 – 1480. | en_US |
dc.identifier.citedreference | Zhang J, Niu C, Ye L, Huang H, He X, Tong WG, Ross J, Haug J, Johnson T, Feng JQ, Harris S, Wiedemann LM, Mishina Y, Li L. 2003. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425: 836 – 841. | en_US |
dc.identifier.citedreference | Adams GB, Chabner KT, Alley IR, Olson DP, Szczepiorkowski ZM, Poznansky MC, Kos CH, Pollak MR, Brown EM, Scadden DT. 2006. Stem cell engraftment at the endosteal niche is specified by the calcium‐sensing receptor. Nature 439: 599 – 603. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.